Clinical Trial Update: Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of perifosine for metastatic, androgen-independent prostate cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED